Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

The rash resolved after stopping ponatinib.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Dutasteride likely doesn't harm wild fish due to low environmental levels, but more research is needed on bioaccumulation.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Hibiscus root extract reduces inflammation in rats.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A reliable method was developed to measure candesartan in human plasma.

Tannin effectively inhibits and degrades biofilms from certain bacteria and fungi.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

JAK inhibitors show promise for treating various skin diseases.

AQB reduces harmful skin changes in systemic sclerosis.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.